Case Type: Mergers & Acquisitions

MarketAxess Holdings Inc. (NASDAQ: MKTX) related to its sale to Intercontinental Exchange, Inc. Under the terms of the proposed transaction, MarketAxess shareholders are expected to receive $167.00 per share in cash.

Sanara MedTech Inc. (NASDAQ: SMTI) related to its sale to MiMedx Group, Inc. Under the terms of the proposed transaction, Sanara shareholders are expected to receive $33.00 in cash and 0.4735 shares of MiMedx common stock for each share of Sanara common stock.

CBIZ, Inc. (NYSE: CBZ) related to its sale to Grant Thornton Advisors LLC. Under the terms of the proposed transaction, CBIZ shareholders are expected to receive $55.00 per share in cash.

Luxfer Holdings PLC (NYSE: LXFR) related to its sale to affiliates of Wynnchurch Capital L.P. Under the terms of the proposed transaction, Luxfer shareholders are expected to receive $17.37 per share in cash.

Forte Biosciences, Inc. (NASDAQ: FBRX) related to its sale to argenx BV. Under the terms of the proposed transaction, Forte Biosciences shareholders are expected to receive $77.00 per share in cash.

Safety Insurance Group Inc. (NASDAQ: SAFT) related to its sale to an affiliate of Mapfre S.A. Under the terms of the proposed transaction, Safety Insurance stockholders are expected to receive $105.00 per share in cash.

Neuphoria Therapeutics, Inc. (NASDAQ: NEUP) related to its merger with Scancell Holdings plc. Upon completion of the proposed transaction, Neuphoria stockholders are expected to own 11.1% of the combined company.

Passage Bio, Inc. (NASDAQ: PASG) related to its merger with Remix Therapeutics, Inc.

PBCO Financial Corporation (OTCID: PBCO) related to its merger with Northrim Bancorp, Inc. Under the terms of the proposed transaction, PBCO shareholders are expected to receive 1.160 shares of Northrim common stock for each share of PBCO common stock.

Northrim Bancorp, Inc. (NASDAQ: NRIM) related to its merger with PBCO Financial Corporation.